169 related articles for article (PubMed ID: 17052977)
21. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.
Butkiewicz N; Yao N; Zhong W; Wright-Minogue J; Ingravallo P; Zhang R; Durkin J; Standring DN; Baroudy BM; Sangar DV; Lemon SM; Lau JY; Hong Z
J Virol; 2000 May; 74(9):4291-301. PubMed ID: 10756044
[TBL] [Abstract][Full Text] [Related]
22. Structural characterization and polymorphism analysis of the NS2B-NS3 protease from the 2017 Brazilian circulating strain of Yellow Fever virus.
Noske GD; Gawriljuk VO; Fernandes RS; Furtado ND; Bonaldo MC; Oliva G; Godoy AS
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129521. PubMed ID: 31931019
[TBL] [Abstract][Full Text] [Related]
23. Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor.
Brinkworth RI; Fairlie DP; Leung D; Young PR
J Gen Virol; 1999 May; 80 ( Pt 5)():1167-1177. PubMed ID: 10355763
[TBL] [Abstract][Full Text] [Related]
24. Potential Dual Role of West Nile Virus NS2B in Orchestrating NS3 Enzymatic Activity in Viral Replication.
Tseng AC; Nerurkar VR; Neupane KR; Kae H; Kaufusi PH
Viruses; 2021 Jan; 13(2):. PubMed ID: 33572517
[TBL] [Abstract][Full Text] [Related]
25. The two-component NS2B-NS3 proteinase represses DNA unwinding activity of the West Nile virus NS3 helicase.
Chernov AV; Shiryaev SA; Aleshin AE; Ratnikov BI; Smith JW; Liddington RC; Strongin AY
J Biol Chem; 2008 Jun; 283(25):17270-8. PubMed ID: 18442976
[TBL] [Abstract][Full Text] [Related]
26. Mutagenesis of the NS3 protease of dengue virus type 2.
Valle RP; Falgout B
J Virol; 1998 Jan; 72(1):624-32. PubMed ID: 9420267
[TBL] [Abstract][Full Text] [Related]
27. Functional characterization of cis and trans activity of the Flavivirus NS2B-NS3 protease.
Bera AK; Kuhn RJ; Smith JL
J Biol Chem; 2007 Apr; 282(17):12883-92. PubMed ID: 17337448
[TBL] [Abstract][Full Text] [Related]
28. Activation of the West Nile virus NS3 protease: molecular dynamics evidence for a conformational selection mechanism.
Ekonomiuk D; Caflisch A
Protein Sci; 2009 May; 18(5):1003-11. PubMed ID: 19388022
[TBL] [Abstract][Full Text] [Related]
29. Mutagenesis of the West Nile virus NS2B cofactor domain reveals two regions essential for protease activity.
Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
J Gen Virol; 2008 Apr; 89(Pt 4):1010-1014. PubMed ID: 18343843
[TBL] [Abstract][Full Text] [Related]
30. Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation.
Robin G; Chappell K; Stoermer MJ; Hu SH; Young PR; Fairlie DP; Martin JL
J Mol Biol; 2009 Feb; 385(5):1568-77. PubMed ID: 19059417
[TBL] [Abstract][Full Text] [Related]
31. Phosphonate inhibitors of West Nile virus NS2B/NS3 protease.
Skoreński M; Milewska A; Pyrć K; Sieńczyk M; Oleksyszyn J
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):8-14. PubMed ID: 30362835
[TBL] [Abstract][Full Text] [Related]
32. Context-Dependent Cleavage of the Capsid Protein by the West Nile Virus Protease Modulates the Efficiency of Virus Assembly.
VanBlargan LA; Davis KA; Dowd KA; Akey DL; Smith JL; Pierson TC
J Virol; 2015 Aug; 89(16):8632-42. PubMed ID: 26063422
[TBL] [Abstract][Full Text] [Related]
33. A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease.
Brecher M; Li Z; Liu B; Zhang J; Koetzner CA; Alifarag A; Jones SA; Lin Q; Kramer LD; Li H
PLoS Pathog; 2017 May; 13(5):e1006411. PubMed ID: 28542603
[TBL] [Abstract][Full Text] [Related]
34. NMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B-NS3 protease.
Su XC; Ozawa K; Yagi H; Lim SP; Wen D; Ekonomiuk D; Huang D; Keller TH; Sonntag S; Caflisch A; Vasudevan SG; Otting G
FEBS J; 2009 Aug; 276(15):4244-55. PubMed ID: 19583774
[TBL] [Abstract][Full Text] [Related]
35. Expression and purification of a two-component flaviviral proteinase resistant to autocleavage at the NS2B-NS3 junction region.
Shiryaev SA; Aleshin AE; Ratnikov BI; Smith JW; Liddington RC; Strongin AY
Protein Expr Purif; 2007 Apr; 52(2):334-9. PubMed ID: 17189703
[TBL] [Abstract][Full Text] [Related]
36. A P2 and P3 substrate specificity comparison between the Murray Valley encephalitis and West Nile virus NS2B/NS3 protease using C-terminal agmatine dipeptides.
Ang MJ; Li Z; Lim HA; Ng FM; Then SW; Wee JL; Joy J; Hill J; Chia CS
Peptides; 2014 Feb; 52():49-52. PubMed ID: 24333681
[TBL] [Abstract][Full Text] [Related]
37. Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review.
Wahaab A; Mustafa BE; Hameed M; Stevenson NJ; Anwar MN; Liu K; Wei J; Qiu Y; Ma Z
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062249
[TBL] [Abstract][Full Text] [Related]
38. Exploring the binding of peptidic West Nile virus NS2B-NS3 protease inhibitors by NMR.
Kang C; Gayen S; Wang W; Severin R; Chen AS; Lim HA; Chia CS; Schüller A; Doan DN; Poulsen A; Hill J; Vasudevan SG; Keller TH
Antiviral Res; 2013 Feb; 97(2):137-44. PubMed ID: 23211132
[TBL] [Abstract][Full Text] [Related]
39. Deciphering the molecular basis for nucleotide selection by the West Nile virus RNA helicase.
Despins S; Issur M; Bougie I; Bisaillon M
Nucleic Acids Res; 2010 Sep; 38(16):5493-506. PubMed ID: 20421212
[TBL] [Abstract][Full Text] [Related]
40. Steady-state cleavage kinetics for dengue virus type 2 ns2b-ns3(pro) serine protease with synthetic peptides.
Khumthong R; Niyomrattanakit P; Chanprapaph S; Angsuthanasombat C; Panyim S; Katzenmeier G
Protein Pept Lett; 2003 Feb; 10(1):19-26. PubMed ID: 12625822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
